- Home
- HOMB vs INDV Comparison
HOMB vs INDV Comparison
Compare HOMB & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HOMB | INDV |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.4B |
| IPO Year | 2006 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HOMB | INDV |
|---|---|---|
| Price | $27.86 | $38.38 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $31.50 | N/A |
| AVG Volume (30 Days) | 1.4M | ★ 1.6M |
| Earning Date | 04-15-2026 | 06-08-2026 |
| Dividend Yield | ★ 3.17% | N/A |
| EPS Growth | 19.90 | ★ 8100.00 |
| EPS | 0.60 | ★ 0.69 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $10.99 | N/A |
| Revenue Next Year | $5.14 | N/A |
| P/E Ratio | ★ $45.80 | $55.20 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $25.50 | $13.45 |
| 52 Week High | $30.83 | $41.00 |
Technical Indicators
Market Signals| Indicator | HOMB | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 63.76 | 59.69 |
| Support Level | $27.80 | $35.36 |
| Resistance Level | $28.59 | $41.00 |
| Average True Range (ATR) | 0.42 | 1.33 |
| MACD | 0.15 | 0.09 |
| Stochastic Oscillator | 95.58 | 93.44 |
Price Performance
Historical ComparisonAbout HOMB Home BancShares Inc.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The company has one reportable segment: The Banking Segment.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).